North Valley Eye Care Introduces Valeda Treatment

The new light-based therapy helps slow vision loss for patients suffering from macular degeneration.

Updated on Oct. 28, 2026 in Alzheimer’s

North Valley Eye Care Introduces Valeda Treatment

Live Poll

Do you believe new medical technologies are effectively improving quality of life for aging patients?

Dr. Joel Barthellow of North Valley Eye Care in Chico has introduced the Valeda machine to treat macular degeneration. This new light-based procedure is designed to slow the progression of the non-hereditary eye disease in older adults.

Why it matters

Macular degeneration is the leading cause of vision loss for Americans aged 55 and older, yet no cure currently exists for the condition. The Valeda system offers a way to manage symptoms and preserve sight for the millions of people impacted by the disease.

Macular degeneration impacts more than 20 million Americans and serves as the leading cause of vision loss for adults aged 55 and older. North Valley Eye Care has integrated 5 Valeda machines to provide treatments that take less than 10 minutes.

The players

Dr. Joel Barthellow

Dr. Joel Barthellow is a medical practitioner at North Valley Eye Care in Chico who is overseeing the implementation of new vision therapies.

North Valley Eye Care

North Valley Eye Care is a medical facility in Chico that provides specialized eye health services to the local community.

Jim Hauenstein

Jim Hauenstein is an 86-year-old patient who is receiving treatment for macular degeneration at the Chico facility.

The details

The procedure utilizes specific light frequencies directed into the eyes twice per session to treat the retina. While not a cure, the therapy is specifically used to slow vision loss in patients such as 86-year-old Jim Hauenstein.

Timeline

  1. The Valeda machines were introduced at North Valley Eye Care in October 2026.

The Big Picture

This introduction marks a departure from standard macular degeneration management protocols established by the AREDS2 clinical trial standards. The move signals a broader transition toward light-based therapies as an adjunct to traditional patient care.

Patients suffering from macular degeneration now have access to a non-invasive, 10-minute treatment option at the Chico clinic. Those interested in the procedure should consult with their doctor to determine if light-based therapy is appropriate for their specific diagnosis.

The takeaway

Patients experiencing vision changes should seek regular screenings to catch signs of macular degeneration as early as possible. While new technologies offer hope for slowing disease progression, maintaining consistent monitoring remains essential for long-term eye health.

Further reading

For more information on current vision and neurological health trends, visit the Alzheimer’s section.

Source note: This article includes information reported by Action News Now.

Live Poll

Do you believe new medical technologies are effectively improving quality of life for aging patients?